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Conclusion: The PD-1 expression on T-cells can be induced
by HBV infected cells HepG2.2.15, and cytokines
expression and cytotoxic test were recovered by blocking
PD-1/PDL-1 interaction. So, HBV infection may regulate the
PD-1 expression and function, leading to immune tolerance
during HBV infection.
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Background and Aims: Hepatitis B virus (HBV) infection
has been closely associated with the development of
hepatocellular carcinoma (HCC). In the past few years,
we have identiﬁed and constructed two major types of
pre-S mutants in ground glass hepatocytes, Type I and
Type II GGHs, which pre-S mutants with deletions over
the pre-S1 region (nt 3040 to 3111) and pre-S2 region
(nt 4 to 57), respectively. The mutant pre-S proteins are
retained in endoplasmic reticulum (ER) and induce ER
stress and DNA damage. Pre-S2 mutant transgenic mice can
develop dysplasia of hepatocytes and HCC. Furthermore,
the presence of pre-S mutants can predict the development
of HCC. Therefore, pre-S mutants are now considered to
be viral oncoproteins. The status of pre-S mutants in HCC
tissues and its signiﬁcance has not yet been clariﬁed.
Materials and Methods: The prevalence of pre-S mutants
in HBV-related HCCs was studied on tumor tissues obtained
from 34 adults and 19 childhood patients. Tumor tissues from
8 Woodchuck hepatitis virus (WHV)-infected HCCs were also
studied for comparison.
Results: The prevalence rate of pre-S mutants in HCC
tissues from human adults, children, and woodchucks
were 55.88%, 89.74% and 62.50%, respectively. The pre-
S2 mutants prevailed over the pre-S1 deletion mutants
in human HCC, 84.21% in adults and 88.24% in children,
whereas only pre-S1 mutants (100%) were detected in
Woodchuck HCC tissues.
Conclusion: Given the high prevalence of pre-S2 mutants in
human HCC tissues, pre-S2 mutant may play a major role
in human HBV hepatocarcinogenesis, while pre-S1 mutants-
induced pathway such as ER stress signals might play a
major role in woodchuck HCC. The high prevalence of pre-
S2 mutant is childhood HCC is interesting and should shed
light on HBV hepatocarcinogenesis, considering the high
cirrhosis rate and the rapid development of HBV-related
HCC.
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Introduction: Before 1990, prevalence of HBV infection
was approximately 15% in whole population of Mongolia.
Therefore, there was introduced HBV vaccination as
mandatory immunization since 1991. But, by the study
conducted 5 years ago, the efﬁcacy of HBV vaccination
in the rural nomadic children was signiﬁcantly lower than
urban. So, government implemented some measures for
increase the efﬁcacy of HBV vaccination in rural.
Aim: To study the prevalence of HBV infection and efﬁcacy
of HBV vaccination of children living in provincial centre
and rural nomadic.
Method and subjects: There were selected randomly and
matching age and sex 146 children from provincial centre
(Selenge province), 79 from rural nomadic living population
(Ongon somon of Suhbaatar province) in 2006 2007. In all
serum of subjects were analyse for HBsAg and anti-HBs.
Results: The results are shown in the table.
Age Anti-HBs (%) HBsAg (%)
Selenge Ongon Selenge Ongon
1 76.5 55.6 0 0
3 57.9 90.0 0.5 0
5 31.6 50.0 10.5 0
7 36.8 10.0 0 0
9 35.3 20.0 5.9 20.0
11 30.0 10.0 5.0 10.0
13 4.5 10.0 0 10.0
15 15.0 20.0 10.0 20.0
Mean 34.6 32.9 4.6 7.6
Conclusions: 1. After 15 years of the vaccination the
prevalence of HBV infection decreased to 2 3 fold. 2. The
efﬁcacy of HBV vaccination in rural nomadic children has
possibilities as urban or in another developed country’s
children.
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Background: In hepatitis B e antigen (HBeAg)-positive
patients, the HBeAg seroconversion rate reaches 32% when
treated with the pegylated interferon alfa (Peg-IFN). There
are many other anti-viral drugs available for treating chronic
hepatitis B (CHB) patients. It would therefore be beneﬁcial
to include a pre-treatment evaluation to ﬁnd which
patients should be treated with interferon. For the goal
of individualizing anti-HBV therapy, a pharmacogenomics
study to screen a genetic algorism using human genotypes
to predict the responsiveness of HBeAg-positive patients
who were under Peg-IFN treatments has been developed.
Methods: In this study, single nucleotide polymorphisms
(SNPs) were selected from genes involved in pathways
related to IFN signaling and immunomodulation. More than
250 SNPs from 30 candidate genes were genotyped with
samples collected from 180 Peg-IFN treated CHB patients.
After a serious of computer-aided analysis, a total of 30
polymorphisms were found to be strongly associated with
the responsiveness. A panel of SNPs was further selected to
predict the treatment outcomes.
Results: We discovered genetic predisposition factors which
can differentiate responders from non-responders in PEG-
IFN treated CHB patients. One of the algorithms developed
can use SNPs from a few genes to predict the treatment
